Opioids
More on Opioids
Washington, D.C. (March 3, 2022)—Today, Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, and senior Committee Member Rep. Mark DeSaulnier,
Washington, D.C. (December 16, 2021)—Today, Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, and senior Committee Member Rep. Mark DeSaulnier, issued the following statements after the U.S. District Court for the Southern District of New York rejected Purdue Pharma's plan of reorganization, which would have granted sweeping immunity to members of the Sackler family for their role in flooding American communities with OxyContin and fueling the nation's opioid epidemic.
WASHINGTON - Rep. Jim Cooper (TN-05) introduced a bill to require federal entities to include reasonable conditions in awarding naming rights for public spaces and institutions. The Government Integrity is Not for Trade or Sale (GIFTS) Act is designed to help keep the names of corrupt individuals off public institutions.
Washington, D.C. (September 16, 2021)—Today, Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, senior Committee Member Rep. Mark DeSaulnier, Sen. Elizabeth Warren, and Sen. Richard Blumenthal issued the following statement regarding the decision by the U.S. Trustee (UST), a component of the Department of Justice (DOJ) responsible for overseeing the administration of bankruptcy cases, to appeal the confirmation of Purdue Pharma's bankruptcy plan.
Washington, D.C. (September 1, 2021)—Today, Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, and senior Committee Member Rep. Mark DeSaulnier, issued the following statement following the confirmation of Purdue Pharma's bankruptcy plan of reorganization, which granted sweeping immunity to members of the Sackler family for their role in flooding American communities with OxyContin and fueling the nation's opioid epidemic.
Washington, D.C. - Rep. Carolyn B. Maloney (D-N.Y.), Chairwoman of the Committee on Oversight and Reform, United States Representative Mark DeSaulnier (D-Calif.), and United States Senators Elizabeth Warren (D-Mass.) and Richard Blumenthal (D-Conn.) sent a letter urging the Department of Justice (DOJ) to file an immediate appeal of Purdue Pharma, L.P.'s bankruptcy plan of reorganization that would prevent the Sackler family from being held accountable for the opioid crisis.
Washington, D.C. — Today, United States Senators Elizabeth Warren (D-Mass.), Dick Durbin (D-Ill.), and Richard Blumenthal (D-Conn.), and United States Representatives Jerrold Nadler (D-N.Y.) and Carolyn B. Maloney (D-N.Y.) announced legislation to prohibit the use of non-consensual, non-debtor releases that have helped entities and individuals, like members of the Sackler family, escape accountability for wrongdoing through bankruptcy proceedings.
Washington, D.C. (July 8, 2021)—Today, Rep. Carolyn B. Maloney, the Chairwoman of the Committee on Oversight and Reform, and senior Committee Member Rep. Mark DeSaulnier, issued this statement following news that additional state Attorneys General reached an agreement with Purdue Pharma on a bankruptcy settlement:
Washington, D.C. (June 30, 2021)—Rep. Carolyn B. Maloney, Chairwoman of the Committee on Oversight and Reform, and senior Committee Member Rep. Mark DeSaulnier sent a letter to Attorney General Merrick Garland urging the Department of Justice (DOJ) to vote against the plan of reorganization Purdue Pharma has proposed as part of its Chapter 11 bankruptcy.